The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Access to diagnostics and treatment of neuroendocrine tumors (NETs): The difference between patient perception and reality.
 
Simone Leyden
Consulting or Advisory Role - Ipsen
 
Teodora Kolarova
No Relationships to Disclose
 
Catherine Bouvier
No Relationships to Disclose
 
Martyn E. Caplin
Honoraria - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications; Ipsen
 
Siobhan Conroy
No Relationships to Disclose
 
Philippa Davies
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Ipsen
 
Sugandha Dureja
Employment - Fortis Memorial Research Institute
 
Massimo Falconi
Honoraria - Advanced Accelerator Applications; Celgene; Merck Sharp & Dohme; Novartis/Ipsen
Travel, Accommodations, Expenses - Johnson & Johnson
 
Piero Ferolla
Consulting or Advisory Role - Ipsen; Lexicon; Merck; Novartis
Research Funding - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; Merck; Novartis
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Genentech; Ipsen; Merck; Novartis
Consulting or Advisory Role - Aduro Biotech; Aduro Biotech; Forty Seven; Genentech/Roche; Incyte; ipsen; Jounce Therapeutics; Merck; Newlink Genetics
Research Funding - Aduro Biotech (Inst); EpicentRx (Inst); Forty seven (Inst); Genentech/Roche (Inst); Jounce Therapeutics (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); TERUMO (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Grace Goldstein
Stock and Other Ownership Interests - Endocyte; Johnson & Johnson; Progenics; Takeda
 
Rodney J. Hicks
No Relationships to Disclose
 
Benjamin James Lawrence
Employment - Canopy Cancer Care
Stock and Other Ownership Interests - Canopy Cancer Care
 
Yoshiyuki Majima
No Relationships to Disclose
 
David C. Metz
Consulting or Advisory Role - Advanced Accelerator Applications; lexicon; wren laboratories
Research Funding - Advanced Accelerator Applications; lexicon; wren laboratories
Expert Testimony - Mylan
 
Dermot O'Toole
Honoraria - Ipsen; Novartis; Prime Oncology
Speakers' Bureau - Ipsen; Novartis; Prime Oncology
Travel, Accommodations, Expenses - Ipsen; Novartis; Prime Oncology; Roche
 
Philippe B. Ruszniewski
Honoraria - Advanced Accelerator Applications; Ipsen; Keocyt; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Keocyt; Novartis
Research Funding - Ipsen
Expert Testimony - Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Bertram Wiedenmann
No Relationships to Disclose
 
Ron Hollander
No Relationships to Disclose